Clinical Trial Detail

NCT ID NCT03504488
Title CAB-ROR2-ADC Safety and Efficacy Study in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioAtla, LLC
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

sarcoma

Advanced Solid Tumor

Therapies

BA3021

Age Groups: senior adult

No variant requirements are available.